ESR1 and breast cancer: Here, we showed that ER-positive breast cancer cells overexpressing GRHL2 significantly increased epithelial markers and behavior as compared to those with only endogenous levels of GRHL2, indicating that GRHL2 retains its potent role in epithelial identity when expressed at high levels.